These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32032675)

  • 1. Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study.
    Moh AMC; Pek SLT; Liu J; Wang J; Subramaniam T; Ang K; Sum CF; Kwan PY; Lee SBM; Tang WE; Lim SC
    Diabetes Res Clin Pract; 2020 Mar; 161():107992. PubMed ID: 32032675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis.
    Moh AMC; Wang J; Tan C; Ang SF; Ang K; Subramaniam T; Sum CF; Kwan PY; Lee SBM; Tang WE; Lim SC
    Diabetes Res Clin Pract; 2019 Nov; 157():107812. PubMed ID: 31401149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST; Xu JM; Wang M; Chen FL; Ding G
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes].
    Czyzewska J; Wasilewska K; Kamińska J; Koper O; Kemona H; Jakubowska I
    Pol Merkur Lekarski; 2012 Feb; 32(188):98-102. PubMed ID: 22590912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
    Ihara K; Skupien J; Kobayashi H; Md Dom ZI; Wilson JM; O'Neil K; Badger HS; Bowsman LM; Satake E; Breyer MD; Duffin KL; Krolewski AS
    Diabetes Care; 2020 Nov; 43(11):2760-2767. PubMed ID: 32887710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.
    Koluman BU; Mutluay R; Derici UB; Arinsoy T; Senlik Z; Bahar B; Sancak B; Oktan SO; Sindel S
    Clin Nephrol; 2013 Jul; 80(1):9-16. PubMed ID: 23458176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
    Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
    J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness is an independent predictor for albuminuria progression among Asians with type 2 diabetes-A prospective cohort study.
    Zhang X; Low S; Sum CF; Tavintharan S; Yeoh LY; Liu J; Li N; Ang K; Lee SB; Tang WE; Lim SC
    J Diabetes Complications; 2017 Jun; 31(6):933-938. PubMed ID: 28392041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes.
    Niu Y; Zhang W; Yang Z; Li X; Wen J; Wang S; Zhang H; Wang X; Zhou H; Fang W; Qin L; Su Q
    BMC Cardiovasc Disord; 2015 Aug; 15():86. PubMed ID: 26260869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.
    Anand DV; Lim E; Darko D; Bassett P; Hopkins D; Lipkin D; Corder R; Lahiri A
    J Am Coll Cardiol; 2007 Dec; 50(23):2218-25. PubMed ID: 18061069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus.
    Feng G; Gao JL; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C
    Acta Diabetol; 2017 Nov; 54(11):1047-1055. PubMed ID: 28894973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nomogram for predicting the risk of new-onset albuminuria based on baseline urinary ACR, orosomucoid, and HbA1c in patients with type 2 diabetes.
    Xu Y; Shan X; Wang H
    J Diabetes Complications; 2021 Dec; 35(12):108058. PubMed ID: 34635404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
    Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
    Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin in diabetic osteopathy.
    Valentini A; Cianfarani MA; Federici M; Tarantino U; Bertoli A
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):49-55. PubMed ID: 31757570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.